The principal medical science director at Genentech spoke about the decisions behind the tools being used for measurement, and what the neurologists can get from the data.
Laura Julian, PhD
Advertisement
Articles by Laura Julian, PhD
Advertisement
Latest Updated Articles
Laura Julian, PhD: The Floodlight Open MS DatabasePublished: January 13th 2019 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
2
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
3
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
4
B-Cell Modulator Obexelimab Shows Pronounced Relapse Reduction in Phase 2 MoonStone Trial
5
